Trial intelligence / Profile preview

Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy

NCT00067158Phase 3Completed

Sponsor
New York University
Start
Apr 2003
Primary completion
Jul 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of nicotine in Tobacco Use Disorder (TUD), sponsored by New York University. Started Apr 2003; status: completed.

02

Drugs

nicotine
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00067158.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00067158.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call